Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.

Hims & Hers Health, Inc.

Hims & Hers Health ( ($HIMS) ) has fallen by -11.39%. Read on to learn why. Hims & Hers Health shares fell -11.39% over the past week as investors ...

Hims & Hers Health: Growth Story Shakes Investor Nerves

Shares of Hims & Hers Health ($HIMS), a U.S. telehealth firm, fell over 7% in premarket trading on Tuesday after reporting a more-than-expected Q2 ...

Hims & Hers Stock (HIMS) Slides as GLP-1 Push Swallows Q2 Profits and Widens Loss

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Hims & Hers Health (HIMS), Lifestance Health Group (LFST) and DaV...

Analysts Offer Insights on Healthcare Companies: Hims & Hers Health (HIMS), Lifestance Health Group (LFST) and DaVita (DVA)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Silence Therapeutics (SLN), Hims & Hers Health (HI...

Analysts Conflicted on These Healthcare Names: Silence Therapeutics (SLN), Hims & Hers Health (HIMS) and Syndax Pharmaceuticals (SNDX)

Telehealth company Hims & Hers Health ($HIMS) will announce its second-quarter results after the market closes on Monday, August 10. Ahead of Q2 ea...

Hims & Hers Q2 Earnings Alert – Truist Says HIMS Stock Is ‘Well-Positioned’ for Revenue Beat Today

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Hims & Hers Health (HIMS) and Dianthus Therapeutic...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS) and Dianthus Therapeutics (DNTH)

Telehealth platform Hims & Hers Health ($HIMS) will announce its second-quarter results on August 10. HIMS stock rose 6.5% to close at $31.59 on Fr...

Hims & Hers Q2 Earnings Preview: Options Traders Brace for a 14.5% Move in HIMS Stock

Hims & Hers Health ( ($HIMS) ) has fallen by -9.90%. Read on to learn why. Hims & Hers Health shares slid 9.90% over the past week as investor nerves


Hims & Hers Health Slides as Investors Turn Cautious

On Monday, August 10, Rocket Lab ($RKLB), Hims & Hers ($HIMS), and Quantum Computing ($QUBT) will release their earnings. All three companies will ...

Polymarket Odds: Will RKLB, HIMS, QUBT Beat Earnings on Monday?

Retail investors are feeling less healthy about the prospects of Hims & Hers ($HIMS) as it gets set to report Q2 earnings next week – August 10th. ...

Retail Investors Send in Sick Notes for HIMS Stock Ahead of Q2 Earnings

Hims & Hers Health ( ($HIMS) ) has fallen by -8.17%. Read on to learn why. Hims & Hers Health shares fell 8.17% over the past week as investors rea...

Hims & Hers Health Faces Mounting Regulatory Heat

Shares in telehealth provider Hims & Hers Health ($HIMS) popped by more than 5% on Thursday morning after plunging by almost 15% on Thursday. This ...

Hims & Hers Stock Jumps on Vow to ‘Vigorously’ Defend Against FTC’s ‘Baseless Claims’

Bank of America Securities analyst Allen Lutz reiterated a Hold rating on Hims & Hers Health yesterday and set a price target of $30.00. The compan...

Hims & Hers Health (HIMS) Receives a Hold from Bank of America Securities

Shares in telehealth provider Hims & Hers ($HIMS) tumbled about 12% on Wednesday afternoon. This came as the U.S. consumer protection watchdog drag...

Hims & Hers Health Stock Sinks on Privacy, Deceptive Billing Lawsuit

Truist Financial analyst Jailendra Singh maintained a Hold rating on Hims & Hers Health yesterday and set a price target of $27.00. Singh covers th...

Hims & Hers Health (HIMS) Receives a Hold from Truist Financial

In a report released today, Jailendra Singh from Truist Financial reiterated a Hold rating on Hims & Hers Health, with a price target of $27.00. Si...

The latest update is out from Hims & Hers Health ( ($HIMS) ). Hims & Hers Health, Inc. disclosed that Irene Becklund notified the company on July 1...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	HIMS	$28.15	0.00%	12.72M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	HIMS	$28.15	0%	12.72M
3
4
5
6

HIMS

Get Hims & Hers Health, Inc. Data in Excel

Get Hims & Hers Health, Inc. Data in Excel